Perrigo

US-based Mylan has made an offer to acquire Irish over-the-counter (OTC) and nutritional products maker Perrigo for around $29bn in a cash and stock deal.

An unsolicited and indicative proposal from Mylan regarding a possible offer for the company was sent to Perrigo.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

As per terms of the non-binding proposal, Mylan will pay $205 in a combination of cash and stock for each Perrigo share, representing more than 25% premium to its trading price on 3 April.

Mylan executive chairman Robert Coury said: "This proposal is the culmination of a number of prior discussions between Mylan and Perrigo about the compelling strategic and financial logic of this combination.

"We look forward in the weeks ahead to working with them to capitalise on this tremendous opportunity and working together to create a unique leader with a one-of-a-kind profile in our industry."

"This combination would result in meaningful immediate and long-term value creation, and our proposal is designed to deliver that value to shareholders and other stakeholders of both companies.

"We look forward in the weeks ahead to working with them to capitalise on this tremendous opportunity and working together to create a unique leader with a one-of-a-kind profile in our industry."

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

According to Mylan, the combination of complementary businesses will create a firm with critical mass in specialty brands, generics, OTC, and nutritional products.

Perrigo also supplies infant formulas for the store brand market and healthcare products in North America, Europe, and Australia, as well as Israel and China.

At the end of March, Perrigo completed the acquisition of Belgium’s OTC drugmaker Omega Pharma for around €3.8bn ($4.5bn).

Image: Photograph of the exterior of Perrigo’s Eastern Avenue Office. Photo: courtesy of Perrigo Company.